Free Trial

DIH Holding US (DHAI) Competitors

DIH Holding US logo
$1.00 +0.05 (+5.26%)
(As of 11/15/2024 ET)

DHAI vs. PROF, ARAY, NVRO, INFU, BWAY, DRTS, PDEX, HSAQ, INO, and KRMD

Should you be buying DIH Holding US stock or one of its competitors? The main competitors of DIH Holding US include Profound Medical (PROF), Accuray (ARAY), Nevro (NVRO), InfuSystem (INFU), BrainsWay (BWAY), Alpha Tau Medical (DRTS), Pro-Dex (PDEX), Health Sciences Acquisitions Co. 2 (HSAQ), Inovio Pharmaceuticals (INO), and KORU Medical Systems (KRMD). These companies are all part of the "surgical & medical instruments" industry.

DIH Holding US vs.

DIH Holding US (NASDAQ:DHAI) and Profound Medical (NASDAQ:PROF) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations, community ranking and risk.

DIH Holding US has a net margin of 0.00% compared to Profound Medical's net margin of -349.41%. DIH Holding US's return on equity of 0.00% beat Profound Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
DIH Holding USN/A N/A -3.56%
Profound Medical -349.41%-85.22%-64.87%

Profound Medical received 40 more outperform votes than DIH Holding US when rated by MarketBeat users.

CompanyUnderperformOutperform
DIH Holding USN/AN/A
Profound MedicalOutperform Votes
40
72.73%
Underperform Votes
15
27.27%

DIH Holding US has a beta of -0.65, meaning that its stock price is 165% less volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500.

27.8% of DIH Holding US shares are held by institutional investors. Comparatively, 47.9% of Profound Medical shares are held by institutional investors. 49.6% of DIH Holding US shares are held by company insiders. Comparatively, 1.5% of Profound Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

DIH Holding US has higher revenue and earnings than Profound Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DIH Holding US$64.47M0.63-$8.44MN/AN/A
Profound Medical$7.20M27.43-$28.57M-$1.34-5.98

Profound Medical has a consensus price target of $13.75, suggesting a potential upside of 71.66%. Given Profound Medical's stronger consensus rating and higher possible upside, analysts plainly believe Profound Medical is more favorable than DIH Holding US.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DIH Holding US
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Profound Medical
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25

In the previous week, Profound Medical had 1 more articles in the media than DIH Holding US. MarketBeat recorded 5 mentions for Profound Medical and 4 mentions for DIH Holding US. Profound Medical's average media sentiment score of 1.60 beat DIH Holding US's score of 1.11 indicating that Profound Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DIH Holding US
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Profound Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Profound Medical beats DIH Holding US on 10 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHAI vs. The Competition

MetricDIH Holding USSurgical & medical instruments IndustryBusiness SectorNASDAQ Exchange
Market Cap$40.54M$4.42B$7.22B$8.74B
Dividend YieldN/A41.17%2.38%4.08%
P/E RatioN/A14.6020.7314.54
Price / Sales0.6346.84166.1086.91
Price / CashN/A51.8928.4835.24
Price / Book-1.255.514.815.93
Net Income-$8.44M$13.76M$120.67M$225.73M
7 Day Performance-23.08%-6.52%10.42%-1.34%
1 Month Performance-41.52%2.19%12.53%1.15%
1 Year PerformanceN/A50.62%35.47%24.02%

DIH Holding US Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHAI
DIH Holding US
N/A$1.00
+5.3%
N/AN/A$40.54M$64.47M0.00N/AShort Interest ↓
News Coverage
Positive News
Gap Up
PROF
Profound Medical
2.7486 of 5 stars
$8.16
-6.7%
N/A-18.5%$201.24M$7.88M-6.09150
ARAY
Accuray
4.6587 of 5 stars
$1.98
-7.9%
N/A-32.5%$199.12M$446.55M-11.65987Analyst Downgrade
NVRO
Nevro
2.7403 of 5 stars
$5.33
+4.9%
N/A-73.3%$198.70M$425.17M-2.501,215Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
INFU
InfuSystem
2.08 of 5 stars
$9.11
+16.6%
N/AN/A$194.23M$125.79M151.86499Gap Up
High Trading Volume
BWAY
BrainsWay
4.132 of 5 stars
$10.80
-0.6%
N/A+95.3%$180.14M$31.78M216.04120Earnings Report
Short Interest ↓
Analyst Revision
News Coverage
DRTS
Alpha Tau Medical
2.2736 of 5 stars
$2.27
flat
N/A-27.1%$158.15MN/A-5.6880Upcoming Earnings
Short Interest ↑
News Coverage
PDEX
Pro-Dex
3.2853 of 5 stars
$47.34
+10.9%
N/A+166.8%$154.33M$53.84M30.74140Gap Up
High Trading Volume
HSAQ
Health Sciences Acquisitions Co. 2
N/A$6.13
-0.8%
N/A-18.0%$149.23MN/A0.004News Coverage
INO
Inovio Pharmaceuticals
3.6666 of 5 stars
$5.34
-3.6%
N/A-92.8%$143.84M$591,858.000.00127Analyst Forecast
News Coverage
Gap Up
KRMD
KORU Medical Systems
3.0134 of 5 stars
$2.89
+0.3%
N/A+44.1%$132.28M$28.52M-11.5480Analyst Forecast
News Coverage

Related Companies and Tools


This page (NASDAQ:DHAI) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners